A platform for research: civil engineering, architecture and urbanism
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Eur J Med Res
Agafina, Alina (author) / Aguiar, Valeria Cristina (author) / Rossovskaya, Maria (author) / Fartoukh, Muriel Sarah (author) / Hajjar, Ludhmila Abrahao (author) / Thiéry, Guillaume (author) / Timsit, Jean-François (author) / Gordeev, Ivan (author) / Protsenko, Denis (author) / Carbone, Javier (author)
2024-08-13
Article (Journal)
Electronic Resource
English
Double blind placebo controlled exposure to molds: exposure system and clinical results*
Wiley | 2005
|Elsevier | 2024
|